Tanezumab
- 价格: ¥3375.00/EA
- 发布日期: 2026-05-06
- 更新日期: 2026-07-10
产品详请
| 产地 |
中国
|
| 品牌 |
medlife
|
| 货号 |
PL09104
|
| 用途 |
仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗
|
| 包装规格 |
PL09104-1mg
|
| 纯度 |
≥99%%
|
| CAS编号 |
880266-57-9
|
| 别名 |
Tanezumab
|
| 是否进口 |
否
|
Tanezumab (RN-624) 是一种具有高亲和力和特异性的人源化抗 NGF 单克隆抗体,能阻断 NGF 与周围神经系统中的受体 p75 和 TrkA 结合。Tanezumab 可用于急性和慢性疼痛,如骨关节炎,膝关节和神经痛和带状疱疹后神经痛的研究。
通用名INN:Tanezumab
纯度(Purity:>99%
Formulation:PBS buffer PH7.5
Source:CHO cells
内毒素(Endotoxin level):Please contact with the lab for this information.
产品描述(Description):Tanezumab has been investigated for the treatment of Osteoarthritis, Knee and Neuralgia, Postherpetic.
别名(Alternative names):PF-04383119,RN624
靶点;物种(Specificity target name;species):IGHE[Homo sapiens]
种类(Species):Humanized
受体鉴定(Receptor identification):IgG1-nd
CAS:880266-57-9
存储条件(Storage):
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note:For research use only .